𝔖 Bobbio Scriptorium
✦   LIBER   ✦

NNC 01-0687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia

✍ Scribed by J. Karle; H. Lublin; J. Gerlach; L. Clemmesen; L. Hansen; M. Andersen; J. Andersen; C. Fensbo; M. Sloth-Nielsen; B. K. Skrumsager


Publisher
Springer
Year
1995
Tongue
English
Weight
218 KB
Volume
121
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


No relationship betweenTaq1 a polymorphi
✍ Mihara, Kazuo ;Suzuki, Akihito ;Kondo, Tsuyoshi ;Nagashima, Udai ;Ono, Shingo ;O πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 2 views

The relationship between Taq1 A polymorphism of dopamine D 2 receptor (DRD 2 ) gene and extrapyramidal adverse effects of bromperidol and nemonapride, which are both antipsychotic drugs with selective and potent DRD 2 antagonistic property, was investigated in Japanese schizophrenic inpatients. Twen

Direct demonstration of D1 dopamine rece
✍ Dr. Frederick J. Monsma Jr.; David R. Sibley πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 706 KB

The presence of D, dopamine receptors in the parathyroid gland has been proposed based on the demonstration of dopaminergic regulation of adenylate cyclase activity and parathyroid hormone release in dispersed bovine parathyroid cells. Using a radioiodinated D, selective antagonist [12511-SCH 23982,